Dewpoint will present two posters at AACR Condensate modulators (c-mods) demonstrate robust anti-tumor effects across multiple types of cancer C-mods modulate the oncogenic function of historically undruggable targets MYC and beta catenin BOSTON, March 26, 2025 (GLOBE NEWSWIRE) — Dewpoint Therapeutics Inc. – the leading biotechnology company in transforming condensate biology into medicine, announced today […]

(NYSE:RH), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of RH (“RH” or the “Company”) (NYSE: RH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether RH and certain of its officers and/or directors have engaged in

ATLANTA, March 26, 2025 (GLOBE NEWSWIRE) — Monarch Private Capital, a nationally recognized impact investment firm that develops, finances, and manages a diversified portfolio of projects generating federal and state tax credits, is pleased to announce the financial closing of low-income housing tax credit (LIHTC) equity for Walnut Street Phase I, a new affordable housing

(NASDAQ:FLYW), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Flywire Corporation (“Flywire” or the “Company”) (NASDAQ: FLYW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Flywire and certain of its officers and/or directors have engaged

(NYSE MKT:CLDI), SAN DIEGO and LOS ANGELES, March 26, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, and City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United States, are pleased to

COLUMBUS, Ohio, March 26, 2025 (GLOBE NEWSWIRE) — Heartland Growth Partners (“Heartland”), a private investment firm backed by owner-operators of industrial companies, today announced a strategic partnership with Victory Machine & Fabrication, LLC (“Victory”), a leading provider of millwright and rigging, machining, and metal fabrication services based in Sidney, Ohio. Aaron Wilcox, Victory's largest individual

(NYSE:IBTA), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Ibotta, Inc. (“Ibotta” or the “Company”) (NYSE: IBTA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ibotta and certain of its officers and/or directors have engaged

(NASDAQ:ATYR), SAN DIEGO, March 26, 2025 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced the appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise. Ms. Rayes

(NasdaqGM:NPCE), MOUNTAIN VIEW, Calif., March 26, 2025 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 24th Annual Needham Virtual Healthcare Conference at 3:00pm ET (12:00pm PT) on Tuesday, April 8, 2025. Management

(NYSE:TFX), NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Teleflex Incorporated (“Teleflex” or the “Company”) (NYSE: TFX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Teleflex and certain of its officers and/or directors have engaged